Evidence map›Paper›PMID 31998399›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Antiadipogenesis of

Tanaporn Hengpratom, Apichart Ngernsoungnern, Piyada Ngernsoungnern, Gordon Matthew Lowe, Griangsak Eumkeb

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Antiproliferative, Antiangiogenic, and Antimigrastatic Effects ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tanaporn HengpratomSchool of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.ORCID https://orcid.org/0000-0003-2221-4694
Apichart NgernsoungnernSchool of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Piyada NgernsoungnernSchool of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Gordon Matthew LoweSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.
Griangsak EumkebSchool of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.ORCID https://orcid.org/0000-0003-3884-3022
Suranaree University of Technology · THLiverpool John Moores University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31998399
PMCPMC6969989
OpenAlexW2998385785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.